SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Cadila signs LoI with Microbix Biosystems for Urokinase

07 Jan 2012 Evaluate

Microbix Biosystems Inc., a biotechnology company commercializing novel technologies and Zydus Cadila , an Indian global pharmaceutical company have signed a letter of intent (LoI) to market the Thrombolytic drug, Urokinase in the North American markets.

The two companies expect a definitive agreement to be signed early in 2012, while the anticipated time-line for approval is late 2014. As per the terms of the agreement between both the companies, Zydus is required to provide the funding needed to re-launch the drug in the US and Canada, including an initial commitment, plus milestone based payments.

The estimated market size of the Urokinase use in the US alone is expected to touch $400 million by 2020 between three indications: pulmonary embolism, catheter clerarence and catheter prophylaxis.

Urokinase was acquired by Microbix in 2008 which has since then stepped up efforts to re-introduce the drug in North America.

Zydus Wellness Share Price

499.20 -3.95 (-0.79%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Varun Beverages 474.05
Nestle 1285.65
Britannia Inds 5733.75
LT Foods 422.10
Hatsun Agro Product 979.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×